Literature DB >> 14573778

Quest for controls in molecular genetics.

Wayne W Grody1.   

Abstract

Mesh：

Year:  2003        PMID： 14573778      PMCID： PMC1907341          DOI： 10.1016/S1525-1578(10)60475-8

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  4 in total

Review 1.  NIST physical standards for DNA-based medical testing.

Authors:  Peter E Barker; Michael S Watson; John R Ticehurst; Jennifer C Colbert; Catherine D O'Connell
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Alternative approaches to proficiency testing in molecular genetics.

Authors:  C Sue Richards; Wayne W Grody
Journal:  Clin Chem       Date:  2003-05       Impact factor: 8.327

3.  Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.

Authors:  Susan H Bernacki; Ana K Stankovic; Laurina O Williams; Jeanne C Beck; James E Herndon; Karen Snow-Bailey; Thomas W Prior; Karla J Matteson; Linda M Wasserman; Eugene C Cole; Timothy T Stenzel
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

4.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening.

Authors:  W W Grody; G R Cutting; K W Klinger; C S Richards; M S Watson; R J Desnick
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822
  4 in total
  4 in total

1.  Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms.

Authors:  Andrew G Hadd; Walairat Laosinchai-Wolf; Chris R Novak; Marty R Badgett; Lesley A Isgur; Marianna Goldrick; Cindy R Walkerpeach
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

2.  Cystic fibrosis testing comes of age.

Authors:  Wayne W Grody
Journal:  J Mol Diagn       Date:  2009-04-09       Impact factor: 5.568

3.  A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.

Authors:  Michael Jarvis; Ramaswamy K Iyer; Laurina O Williams; Walter W Noll; Kirk Thomas; Milhan Telatar; Wayne W Grody
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

4.  Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).

Authors:  Justin T Brown; Cora Lahey; Walairat Laosinchai-Wolf; Andrew G Hadd
Journal:  BMC Med Genet       Date:  2006-08-03       Impact factor: 2.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.